NYSE:CVS - CVS Health Stock Price, Price Target & More

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Tuesday, March 13th. Stockholders of record on Monday, April 23rd will be paid a dividend of $0.50 per share on Thursday, May 3rd. This represents a $2.00 annualized dividend and a dividend yield of 2.77%. The ex-dividend date of this dividend is Friday, April 20th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) posted its earnings results on Wednesday, May, 2nd. The pharmacy operator reported $1.48 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.39 by $0.09. The pharmacy operator earned $45.69 billion during the quarter, compared to the consensus estimate of $45.77 billion. CVS Health had a return on equity of 17.45% and a net margin of 3.59%. CVS Health's revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter last year, the company earned $1.17 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for CVS Health.

CVS Health updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share (EPS) guidance of $6.87-7.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.45. CVS Health also updated its Q2 guidance to $1.59-1.64 EPS.

19 Wall Street analysts have issued 1 year target prices for CVS Health's shares. Their predictions range from $68.00 to $99.00. On average, they anticipate CVS Health's share price to reach $86.8750 in the next year. View Analyst Ratings for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Press coverage about CVS stock has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CVS Health earned a coverage optimism score of 0.22 on Accern's scale. They also assigned press coverage about the pharmacy operator an impact score of 43.66 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.89%), Barrow Hanley Mewhinney & Strauss LLC (1.78%), Northern Trust Corp (1.52%), Franklin Resources Inc. (1.20%), Veritas Asset Management LLP (1.12%) and Dimensional Fund Advisors LP (1.06%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Prudential Financial Inc., Element Capital Management LLC, The Manufacturers Life Insurance Company , Boston Partners, Lord Abbett & CO. LLC, Crawford Investment Counsel Inc. and Equity Investment Corp. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Schwab Charles Investment Management Inc., Carmignac Gestion, Barrow Hanley Mewhinney & Strauss LLC, Rockefeller Capital Management L.P., Millennium Management LLC, Russell Investments Group Ltd. and Toronto Dominion Bank. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $72.18.

CVS Health has a market capitalization of $72.79 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]